New Zealand markets open in 7 hours 17 minutes

Olympus Corporation (OCPNF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
14.50-0.10 (-0.68%)
At close: 02:40PM EST

Olympus Corporation

Shinjuku Monolith
3-1 Nishi-Shinjuku 2-chome Shinjuku-ku
Tokyo 163-0914
Japan
81 3 3340 2111
https://www.olympus-global.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full-time employees32,844

Key executives

NameTitlePayExercisedYear born
Mr. Yasuo TakeuchiRepresentative Executive Officer, ESG Officer & Executive Chairman2.54MN/A1957
Mr. Chikashi TakedaExecutive Officer & CFO819.3kN/A1962
Mr. Andre RogganExecutive Officer & CTO1.53MN/AN/A
Stephen KneeboneCorporate Officer & Chief Information Officer4.89MN/AN/A
Mr. Nacho AbiaExecutive Officer & Chief Strategy Officer2.28MN/A1968
Mr. Stefan KaufmannRepresentative Executive Officer, President, CEO & Director4.4MN/A1968
Takaaki SakuraiVice President of Investor RelationsN/AN/AN/A
Ms. Donna MillerHead of HQ Legal and Global General CounselN/AN/AN/A
Shigeto OhtsukiExecutive Officer & Chief Human Resources OfficerN/AN/AN/A
Mr. Tetsuo KobayashiExecutive Officer and Chief Manufacturing & Supply OfficerN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials, such as synthetic bone filler, and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.

Corporate governance

Olympus Corporation’s ISS governance QualityScore as of 1 March 2024 is 1. The pillar scores are Audit: 1; Board: 1; Shareholder rights: 5; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.